{
  "ticker": "IPX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02973746",
  "id": "02973746",
  "pages": 8,
  "price_sensitive": false,
  "date": "20250729",
  "time": "0937",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250729/pdf/06m7w6nps7z94v.pdf",
  "summary": "### **Summary of ASX Announcement \u2013 Appendix 2A (IPERIONX LIMITED)**  \n\n#### **Key Points:**  \n- **Security Issuance Details:**  \n  - **Type:** Placement (previously announced via Appendix 3B)  \n  - **Securities Issued:** **13,566,770 fully paid ordinary shares (IPX)**  \n  - **Issue Price:** **AUD 5.00 per share**  \n  - **Issue Date:** **29 July 2025**  \n  - **Total Proceeds:** **~AUD 67.83 million**  \n\n- **Outstanding Approvals:**  \n  - Shareholder approval still required for directors' participation in placement (433,230 shares).  \n\n- **Post-Issuance Capital Structure:**  \n  - **Total Ordinary Shares on Issue (quoted):** **333,494,624**  \n  - **Unquoted Securities:** Includes performance rights, options, and restricted stock units (various terms and strike prices).  \n\n#### **Actionable Items:**  \n- New ordinary shares (13.57M) commence trading on **ASX (IPX)** from **29 July 2025**.  \n- Monitor for shareholder approval outcome regarding director participation.  \n\n**Note:** No material discrepancies or further capital actions beyond the disclosed placement.",
  "usage": {
    "prompt_tokens": 1771,
    "completion_tokens": 275,
    "total_tokens": 2046,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-28T23:59:50.415316"
}